Introduction {#sec1}
============

Approximately 10--15% of reproductive aged females are affected by a complex endocrine disorder, polycystic ovary syndrome (PCOS).[@bib1] PCOS is associated with multiple factors and has a complex pathogenesis that adversely affecting the health of women.[@bib2] It is known to cause endocrine abnormalities, such as the release of gonadotropin-releasing hormone (GnRH), leading to increased LH secretion and decreased FSH levels. It is also known to affect the hypothalamus--pituitary--ovarian axis and ovarian stromal thecal hyperfunctioning, resulting in chronic oligo-anovulation and hyperandrogenism, leading to not only biochemical but also metabolic and reproductive dysfunction.[@bib3] Adolescents diagnosed with PCOS are also diagnosed with menstrual irregularities, increased waist circumference (WC), impaired glucose tolerance (IGT), subclinical atherosclerosis characterized by visceral fat changes and epicardial fat thickness.[@bib4], [@bib5]

A retrospective cross-sectional study on the prevalence of PCOS carried out in Oman at Sultan Qaboos University Hospital (SQUH) reported a frequency of 7.0%. The overall incidence of PCOS was 2.8 per 1000 patients in 2010. The prevalence was higher among women in the age group of 25--34, especially in the Muscat region, followed by the Dhakliya and Al Batinah regions. The study concluded that the prevalence and diagnosis rate was almost similar to that in global population.[@bib6]

Some studies support a higher risk of developing obesity due to impaired metabolic function in women with PCOS, and the incidence differs from country to country depending on lifestyle, environmental and dietary factors.[@bib7], [@bib8] However, the relationship between PCOS incidence and body composition, especially in infertile women, has not yet been studied. Therefore, this case-control study was designed with the aim of investigating the differences, relative risk and correlation between the incidence of PCOS and anthropometric factors, as well as body composition.

Materials and Methods {#sec2}
=====================

Materials {#sec2.1}
---------

The study data were collected using an Omron HBF 375 Karada Scan Body Composition Monitor--Body Fat Analyser to analyse body composition; an OMRAN Digital BP apparatus was used to measure systolic pressure (SP) and diastolic pressure (DP).

Study participants {#sec2.2}
------------------

This case-control study examined equal numbers of infertile women diagnosed with PCOS and not diagnosed with PCOS from a total of 132 women visiting Al-Bushra Medical Specialty Complex, Muscat for infertility treatment in 2016. PCOS was defined in accordance with the Rotterdam criteria.[@bib9] Criteria for excluding patients from this study included women with hypothyroidism, hyperthyroidism, liver failure, hyperprolactinemia, adrenal hyperplasia and diabetes. Women receiving oral contraceptives, hypoglycaemics and anti-dyslipidaemics were also excluded from the study.

Methods {#sec2.3}
-------

### Anthropometric profile {#sec2.3.1}

All subjects involved in the study underwent physical examination to assess height, weight, waist and hip circumference, total body fat, total skeletal muscle, distribution of fat, body mass index (BMI) and Ideal Body weight (IBW); the parameters were calculated following standard procedures and the instructions supplied with the digital body composition analyser.[@bib10], [@bib13] Hypertension and prehypertension was defined as 140/90 mmHg and 120/80 mmHg, respectively.[@bib11]

### Assessment of body composition {#sec2.3.2}

Body composition and weight were measured in a standardized way[@bib12] following the instructions supplied with the Omron Body Composition analyser.[@bib13] This instrument is approved by the FDA for use in research involving adults and children.

### Medical ethics {#sec2.3.3}

This study was approved by the Institutional Ethics Committee and the study centre. Data were collected only from the patients who provided written consent after the objectives were specified and assurances of privacy, anonymity and confidentiality were given. Every patient was given the liberty to withdraw from the study at any time.

### Statistical analysis {#sec2.3.4}

Each case was given a case number, and the information collected in this study was entered directly into SPSS version 19 (SPSS Inc. Chicago, IL, USA) and was analysed using descriptive statistics such as the mean and standard deviation for continuous numerical data; for categorical data, percentage-frequency distributions were used. Means were compared between groups using the t test, and medians were compared using the post hoc Tukey C test. Logistic regression was used to correlate metabolic factors, waist circumference and PCOS diagnosis. p values of less than 0.05 were considered statistically significant.

Results {#sec3}
=======

Validation of the study design {#sec3.1}
------------------------------

Overall, this was a very good model for predicting PCOS because the Omnibus test of model coefficients showed a highly significant chi-square value of 41.688 (p-value \<0.001). In addition, the Nagelkerke R-squared value was found to be 0.682, implying that 68% of the variation in the outcome variable is explained by the predictors in the model. Altogether, as a model, we found arm subcutaneous fat, leg subcutaneous fat, mean arterial pressure, and age to be the most significant predictors of PCOS.

Body fat composition {#sec3.2}
--------------------

Most of the patients (86%) in the control group exhibited normal visceral fat; in contrast, 62.9% of the PCOS population exhibited normal visceral fat, 7.69% had high visceral fat, and 22.58% had very high visceral fat. A Chi-square analysis showed significant (p = 0.004) differences in visceral fat content between the cases and the control group. Based on these results, visceral fat is elevated in the high and very high category of patients with PCOS and is significantly (p \< 0.001) correlated with the incidence of PCOS ([Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}). The results shown in [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"} show that the total body fat distribution in patients diagnosed with PCOS is significantly (p \< 0.001) higher than that in the control group. The odds ratio showed a 36.6% increase in risk of developing PCOS in patients having higher total body fat. Highly significant (p \< 0.001) correlations were recorded between the incidence of PCOS and total subcutaneous fat (r = 0.296), trunk subcutaneous fat (r = 0.244), arm subcutaneous fat (r = 0.309) and leg subcutaneous fat (r = −0.293).Table 1Stratified comparative analysis of the body composition, blood pressure and anthropometric profile of control and PCOS patients.Table 1FactorsCategoryTotalControlCaseLevel of significanceAge 18--2430291Chi-square = 47.9\
Degrees of freedom = 4\
Probability = 0.000 25--30561640 31--3531922 36--401293 ≥4133--Visceral fat ≤9%Normal945539Chi-square = 11.0\
Degrees of freedom = 2\
Probability = 0.004 10--14%High17314 ≥15Very high1459Total body fat 21--32.9Normal503713Chi-square = 18.4\
Degrees of freedom = 2\
Probability = 0.000 33--38.9High441826 ≥39Very high361125Skeletal muscle \<24.3%Low792653-- 24.3--30.3%Normal513813 30.4--35.3High000 ≥35.4Very high220BMI \<18.5%Underweight541Chi-square = 15.2\
Degrees of freedom = 3\
Probability = 0.002 18.5--25%Normal664022 25--30Overweight261313 \>30Obese35926**Blood pressure profile**Systolic blood pressure mmHg \<120Normal412318Chi-square = 4.09\
Degrees of freedom = 3\
Probability = 0.251 120--130Prehypertension502327 131--140Mild hypertension18513 \>140Moderate hypertension1266Diastolic blood pressure mmHg \<80Normal493613Chi-square = 22.1\
Degrees of freedom = 3\
Probability = 0.000 80--90Prehypertension692542 91--100Mild hypertension413 \>100Moderate hypertension606Mean arterial pressure mmHg \<93Normal413011Chi-square = 18.8\
Degrees of freedom = 3\
Probability = 0.000 93--95Prehypertension301614 96--100Mild hypertension24618 \>100Moderate hypertension311021Waist circumference \<80 cmNormal23212 \>80 cm--\<88 cmOverweight361719 ≥88 cmObese722745Hip circumference 66--96Small39309Chi-square = 19.9\
Degrees of freedom = 3\
Probability = 0.000 96--119Medium632439 119--137Large211011 137--154Extra-large5--5Waist/Hip ratio \<0.76Low risk18153Chi-square = 16.2\
Degrees of freedom = 3\
Probability = 0.001 0.76--0.83Moderate risk15105 0.84--0.9High risk351025 \>0.9Very high risk643133[^1]Table 2Comparative analysis of the anthropometric profile and body composition of control and PCOS patients.Table 2FactorsStudy groupMean ± Std. deviationLevel of significance (2-tailed) 't' testExp (B) odds ratios95% Confidence interval of the differencePearson correlationLowerUpperAge (Years)Control28.24 ± 7.9830.1611.417−3.6060.6060.123PCOS29.74 ± 3.3250.162−3.6160.616Height (cm)Control159.11 ± 6.350.414--−1.2873.105−0.072PCOS158.2 ± 6.40.414−1.2873.105Weight (kg)Control60.67 ± 12.670.001--−12.274−3.2350.286PCOS68.43 ± 13.450.001−12.273−3.237Waist circumference (cm)Control84.83 ± 19.230.0011.071−18.585−6.6350.345\*\*PCOS97.44 ± 15.110.001−18.599−6.621Waist/Hip ratioControl0.85 ± 0.20.080.724−0.1140.00650.345\*\*PCOS0.9 ± 0.130.08−0.1140.0066BMIControl24.12 ± 4.690.001--−6.001−2.1780.355\*\*PCOS28.2 ± 6.080.001−6.0102−2.169Hip circumference (cm)Control99.02 ± 14.970.001−15.844−4.5660.302\*\*PCOS109.22 ± 17.390.001−15.832−4.579Systolic BP (mmHg)Control124.49 ± 14.10.723−5.6463.9270.396\*\*PCOS125.34 ± 13.030.723−5.6533.933Mean Arterial Pressure (mmHg)Control92.77 ± 8.730.0021.528−8.88−1.9880.032PCOS98.2 ± 10.680.002−8.87−1.998Diastolic BP (mmHg)Control76.92 ± 7.570.0010.991−11.589−3.8530.270\*\*PCOS84.64 ± 13.460.001−11.566−3.876Ideal Body Weight (kg)Control55.78 ± 4.550.424−0.9292.1960.334\*\*PCOS55.15 ± 4.520.424−0.9292.196Total Body fat %Control32.53 ± 5.560.0011.366−7.772−2.734−0.070PCOS37.78 ± 8.570.001−7.819−2.686Visceral fat %Control5.47 ± 4.230.0010.96−5.559−1.7210.346\*\*PCOS9.1 ± 6.50.001−5.582−1.699Whole subcutaneous fat %Control27.97 ± 5.670.0010.56−6.799−2.8980.296\*\*PCOS32.82 ± 5.650.001−6.799−2.898Trunk subcutaneous fat %Control25.08 ± 7.820.0011.295−6.568−1.8470.244\*\*PCOS29.29 ± 5.720.001−6.569−1.845Arm subcutaneous fat %Control44.79 ± 11.660.0051.154−8.793−1.6030.309\*\*PCOS49.99 ± 8.930.005−8.788−1.608Leg subcutaneous fat %Control40.42 ± 7.60.0010.608−9.965−3.025−0.293\*\*PCOS46.92 ± 12.050.001−9.971−3.019Whole Skeletal muscle %Control25.6 ± 4.840.0010.9923.574−0.339\*\*PCOS23.32 ± 2.170.0010.9873.579Trunk skeletal muscle %Control19.75 ± 3.050.0011.0553.0140.318\*\*PCOS17.71 ± 2.620.0011.0553.014Arm skeletal muscle %Control26.73 ± 5.10.602−4.08037.0136−0.046PCOS25.26 ± 22.190.603−4.1227.056Leg skeletal muscle %Control36.05 ± 4.540.459−12.4695.6630.065PCOS39.45 ± 36.950.460−12.5515.744[^2][^3]

Skeletal muscle composition {#sec3.3}
---------------------------

Based on the results shown in [Table 2](#tbl2){ref-type="table"}, there is a highly significant (p \< 0.001) negative correlation (−0.339) between total skeletal muscle and the incidence of PCOS. A significant (p \< 0.001) positive O (r = 0.318) correlation was found between trunk skeletal muscle and PCOS. According to [Table 1](#tbl1){ref-type="table"}, 81.42% of patients with PCOS had lower skeletal muscle distribution; this value compares with 42.18% of the population in the control group. No significant difference was found between the cases and the control group.

Anthropometric profile {#sec3.4}
----------------------

As depicted in [Table 1](#tbl1){ref-type="table"}, PCOS is a common disorder in reproductive-aged women between 25 and 30 years, followed by women aged 31--35 years. These results show that there is a significant (p \< 0.001) difference in the age of incidence of PCOS. [Table 2](#tbl2){ref-type="table"} shows a 1.417-fold increase in the risk of developing PCOS compared to the control. A highly significant (p \< 0.001) correlation (r = 0.355) was observed between the incidence of PCOS and BMI, with a higher mean BMI (28.2 ± 6.08 kg/m^2^) compared to that (24.12 ± 4.69 kg/m^2^) of the control group. The percentage of women with normal BMI in the PCOS group (35.48%) is approximately half that of women in the PCOS group (60.93%), and 41.93% were obese compared to 10.93% of women in the control group ([Table 1](#tbl1){ref-type="table"}), and a significantly (p = 0.002) higher number of obese and overweight women were seen in the PCOS group. The mean hip circumference in PCOS patients was 109.22 ± 17.39, a value that was significantly (p \< 0.001) higher than that (99.02 ± 14.97 cm) of women in the control group. Furthermore, 9, 39, 11 and 5 had normal, medium, large and extra-large hip circumference respectively in PCOS patients compared to 30, 24, 10 and nil found to be with normal, medium, large and extra-large hip circumference respectively of women in the control group ([Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}).

Blood pressure {#sec3.5}
--------------

Our results showed ([Table 1](#tbl1){ref-type="table"}) an insignificant difference in systolic pressure between the control and PCOS case groups. However, a highly significant (p \< 0.001) difference was recorded for diastolic and mean blood pressure. Mean arterial pressure was higher in patients with PCOS than in patients in the control group. The odds ratio calculated for mean arterial pressure (MAP) in the PCOS patients was 1.528 times higher than that in the control group. A significant (p \< 0.001) correlation was found between SP (r = 0.396) and DP (r = 0.27) ([Table 2](#tbl2){ref-type="table"}).

Discussion {#sec4}
==========

This study was carried out to determine the body composition of infertile women with PCOS and to compare the relevant factors to those in women without PCOS. The results of our study are encouraging and indicate new ways of treating body fat in PCOS patients. PCOS is a common disorder in reproductive-aged women between 25 and 30 years, and the mean age of incidence of PCOS was 29.74 ± 3.32 years; this value represents a 1.417-fold higher risk of PCOS compared to the control group, similar to the results of a previous report.[@bib14]

Excess abdominal adipose tissue initiates metabolic and endocrine irregularities that impair insulin action, and this interacts with the progression of hyperandrogenism, leading to impaired glucose uptake, which again increases the deposition of visceral fat, independently of body mass index.[@bib15], [@bib16] Our results are on the higher side of numbers observed in similar studies because we observed a higher percentage of women in the high to very high visceral fat category. These results are supported by the highly significant (p \< 0.001) correlation between the incidence of PCOS and elevated waist (r = 0.345) and hip (r = 0.302) circumferences. More PCOS patients were in the category of having a large or extra-large hip circumference than in previous studies, which reported that increased waist and hip circumference are associated with increased incidence of PCOS.[@bib17], [@bib18]

The results showed that the total body fat distribution in patients who have been diagnosed with PCOS was significantly (p \< 0.001) higher than that in the control group, and majority were in the high to very high category. Highly significant (p \< 0.001) correlations were recorded between the incidence of PCOS and total subcutaneous fat, trunk subcutaneous fat, arm subcutaneous fat and leg subcutaneous fat. These results are similar but are at the higher end of the range found in studies measuring adipose tissue depots using ultrasound.[@bib19] Our results showed a correlation between increased amounts of upper body fat, subcutaneous fat in the trunk, arm and legs and decreased insulin sensitivity that was higher than that reported in a recent study.[@bib16], [@bib20] Our results also showed a significantly higher trunk/peripheral fat ratio (p \< 0.001) in infertile PCOS patients than that reported in a previous study.[@bib17]

A case control study reported a higher prevalence of androgen-related fat distribution, improved muscle strength in the biceps, and lower limb and handgrip strength in PCOS patients without improving skeletal muscle ratio.[@bib21] Our results support those of the previous study in that we found a significant (p \< 0.001) negative correlation between total skeletal muscle and the incidence of PCOS and a lower total skeletal muscle percentage compared to the control group. It has also been noted that patients with PCOS were in a lower category of skeletal muscle distribution compared to the population in the control group, and these results support those of a study that found significantly lower total skeletal muscle in a PCOS group compared to a control group.[@bib22] Lower skeletal muscle distribution in the PCOS group, which is associated with infertility, can reduce insulin sensitivity, as reported in 2014.[@bib17]

We observed a highly significant (p \< 0.001) correlation between the incidence of PCOS and BMI. The mean BMI of the PCOS group was higher than that of the control group, and the prevalences of overweight and obesity were significantly (p = 0.002) higher in women with PCOS, showing a similar relationship between PCOS incidence and BMI.[@bib23] In our study, the prevalences of overweight, obesity and central obesity were significantly higher in women with PCOS. These observations support the findings in several studies, which have shown that increased BMI directly and significantly increases the incidence of PCOS.[@bib21], [@bib16] A higher percentage of PCOS patients were in the category of large and extra-large circumference than was reported previously in women only having PCOS.[@bib19] These results also supports the results of previous studies reporting that increased waist and hip circumferences increase the incidence of PCOS and associated complications involving infertility.[@bib24]

A cross-sectional study of 84 patients with PCOS reported higher levels of arterial stiffness, thickness of the carotid intima-media due to hyperlipidaemia and insulin resistance, thereby increasing diastolic function[@bib25] and elevated diastolic blood pressure.[@bib26] Similarly, we noted a highly significant (p \< 0.001) increase in the diastolic and mean blood pressures of PCOS patients. The odds ratio for the mean arterial pressure of PCOS patients was 1.528-fold higher than that of a control group, supporting the findings of these studies.

A limitation of this study is that this study was carried out over a period of only six months and involved patients attending only one private hospital in Muscat. Further consideration of the influence of lifestyle factors, such as dietary intake, physical activity and sedentary behaviour, to the elevated prevalence of obesity in patients with PCOS would assist in determining the aetiology of variations in body fat composition.

Conclusions {#sec5}
===========

Taken together, the results of this study indicate that infertile women with PCOS have a higher percentage of visceral fat, waist circumference, hip circumference, total body fat, total subcutaneous fat, trunk subcutaneous fat, arm subcutaneous fat, leg subcutaneous fat, trunk/peripheral fat ratio, BMI, and elevated diastolic blood pressure than do women PCOS alone, as reported in earlier studies. Similarly, we noted a lower level total skeletal muscle mass and its distribution as compared with women only having PCOS.

Recommendation {#sec6}
==============

It is evident that PCOS, especially in infertile women, is a complex condition; therefore, we recommend further studies that involve more patients, hospitals and regions and extending the study period to observe concrete outcomes and their possible implementation in practice.
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[^1]: The results were analysed using the chi-square test in comparison with the control group. p values of less than 0.05 were considered statistically significant.

[^2]: The results were analysed using Student\'s t test followed by a post-hoc Tukey C test in comparison with a control group of patients. Logistic regression analysis was used to correlate factors and the diagnosis of PCOS. p values of less than 0.05 were considered statistically significant.

[^3]: \*\*The Pearson Chi-Square test shows a very significant association at the 0.01 level (2-tailed).
